Finding blood markers that show low oxygen in tumors
Part of Cancer, Lungs & breathing, Mouth & dental clinical trials.
This study looks for substances in blood that may reflect how “low-oxygen” a tumor is. If you have head and neck cancer or non-small cell lung cancer, it may help researchers understand tumor oxygen levels and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of squamous cell cancer in the head and neck, or non-small cell lung cancer
- Or you are a relative of someone with confirmed head and neck squamous cell cancer
- You are able and willing to sign the consent form approved by Stanford’s ethics board (IRB)
- You must be willing to be contacted later for follow-up, if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This study looks for early “biomarkers” (signals in blood or tissue) to see how well head and neck cancer treatments are working over time. It may help doctors adjust treatment sooner based on those early signals.
This study looks at “biomarkers,” which are measurable signs in the body (often in blood or samples), in people with lung or other chest cancers. It may help researchers better understand these cancers and improve how they’re diagnosed or tracked.
This study collects blood and tissue samples from people with cancers of the head, neck, or upper airway to learn how the immune system responds to these cancers. The goal is to find better ways to treat these diseases in the future.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
This study looks for new blood (serum) markers that may show whether anti-cancer therapy is working. If you have cancer or possible cancer and can safely take part, your blood may be used to monitor treatment response over time.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.